Agency IQ
JULY 22, 2024
Commission unveils details on plan for phasing out animal testing for chemicals safety At the REACH and CLP regulators’ meeting in July, the European Commission revealed specifics about its formal schedule to eliminate animal testing used for chemical safety assessment.
Agency IQ
AUGUST 4, 2023
Commission redoubles commitment to reduce animal testing in response to Citizens’ Initiative The European Commission provided its mandatory response to a citizens’ petition this week urging faster action to reduce and ultimately eliminate animal testing within the cosmetics and chemical sectors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
SEPTEMBER 26, 2023
This shift occurred following implementation of the Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative in 2013 and extensive testing of hiPSC-cardiomyocytes with known proarrhythmic drugs.
Agency IQ
JUNE 7, 2024
Notifications will need to include the specific data requirements as laid out in Regulation (EU) No 283/2013 in Sections 1.3, of Part A of the Annex and “evidence that the notified substance or preparation is used as a safener or synergist in at least one plant protection product authorised in at least one Member State.”
The Premier Consulting Blog
APRIL 25, 2023
As a result, the FDA is now required to consider alternatives to animal testing, such as in vitro , in silico , and in chemico tests and models. In this blog post, we examine several alternative approaches to animal testing and how the FDA handles the application of these methods in specific scenarios.
Codon
NOVEMBER 1, 2024
Though my focus in this essay is narrow — I don’t discuss bottlenecks in clinical trials, human disease, or animal testing — I hope others will take on these challenges in similar essays. This essay focuses on how we might do both, specifically for the cell. Subscribe to Asimov Press. Credit: SIngh U.S.
Expert insights. Personalized for you.
40 
Let's personalize your content